SCHEMBL3848293

SCHEMBL3848293

O=C(Nc1nccs1)c1ccc(-c2cnc3ccc(-c4cnn(C(c5ccccc5)(c5ccccc5)c5ccccc5)c4)cn23)c(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
NPC1 O15118 6/20 0.40
RAB9A P51151 6/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
ADORA2A P29274 2/20 0.40
ADORA1 P30542 2/20 0.40
TP53 P04637 1/20 0.39
MAPK1 P28482 1/20 0.39
SCD O00767 1/20 0.39
KCNK3 O14649 1/20 0.39
KCNK9 Q9NPC2 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.37
POLB P06746 2/20 0.37
MAPT P10636 1/20 0.36
ESR2 Q92731 1/20 0.36
HSD17B10 Q99714 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3852108 0.86 CYP1A2 (0.39) ALDH1A1NPC1RAB9AMEN1KMT2A
Hydrochloric Acid SCHEMBL3854256 0.80 ALDH1A1 (0.46) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL3855543 0.79 PIK3CD (0.39) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL3848191 0.76 NPC1 (0.48) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL3854810 0.75 MET (0.36) ALDH1A1NPC1RAB9AMAPK1TSHR
SCHEMBL3848697 0.74 ALDH1A1 (0.45) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL3852747 0.74 ALDH1A1 (0.39) ALDH1A1NPC1RAB9AHSD17B10SMN1; SMN2
SCHEMBL3847097 0.73 PRMT5 (0.38)
SCHEMBL3853878 0.73 CA1 (0.39) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL3847806 0.72 TMIGD3 (0.37) NPC1RAB9AMEN1KMT2AADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed